Diabetes care built for
every Indian.

Mytr.AI combines India's first indigenously engineered insulin pump with an AI-powered metabolic health app — making world-class diabetes management truly affordable and accessible.

Try the Mytr.AI App → Meet the Insulin Pump
The Problem We're Solving

India's diabetes care crisis
is silent — and massive.

77 million Indians live with diabetes. The tools that could transform their care are locked behind an impossible price wall. We're breaking it.

💸
₹3–5L
Cost of an imported insulin pump
Medtronic, Roche, and Abbott pumps are priced beyond reach for over 99% of Indian families — a systemic failure of access that costs lives.
📉
<1%
Indians with access to pump therapy
Despite pump therapy being the clinical gold standard for Type 1 diabetes, virtually no Indian patient can access it — multiple daily injections remain the only option.
🧬
3× higher
Risk of complications without proper control
Poor glucose management triples the risk of blindness, kidney failure, and limb amputation — all preventable with the right therapy, if only it were affordable.
🔬
Zero
Indigenous insulin pumps made in India
Not a single insulin pump has ever been indigenously designed and manufactured in India. Every device is imported. Until now — Mytr.AI is changing that.
Mytr AI Insulin Pump

Precision insulin delivery.
Indian engineering. ₹30,000.

Built from first principles — not licensed, not adapted. The Mytr AI Insulin Pump is designed for India's patients, India's climate, and India's healthcare system.

₹30K
Mytr AI Pump — target price
₹3–5L
Imported pumps today
  • ⚙️
    BLDC Motor Precision

    Maxon EC 9.2 BLDC motor with 256:1 planetary gearhead — 0.025 U/hr minimum basal rate, medical-grade accuracy without imported pricing.

  • 🛡️
    CDSCO-first Regulatory Strategy

    Regulatory pathway designed for India from day one — not retrofitted from international approvals — ensuring faster, compliant local clearance.

  • 📡
    CGM-ready Architecture

    Foundation built for closed-loop CGM integration — the path toward fully automated insulin delivery for Indian patients.

  • 🇮🇳
    Designed for Indian Conditions

    Humidity, temperature extremes, power variability, and India's healthcare infrastructure all factored into every design decision.

Mytr AI Insulin Pump — Prototype in Development

MotorMaxon EC 9.2 BLDC
Gear ratio~256:1
Min. basal rate0.025 U/hr
Drive resolution0.098 µL/step
Device lifespan4 years
ConnectivityBLE + 900 MHz
Regulatory targetCDSCO Class C
Development Progress

Where we are,
and where we're going.

A transparent look at our R&D milestones — from teardown analysis through to CDSCO submission.

Phase 3
Currently in prototype development
15 mo.
Target to MVP from today
Active grant targets
BIRAC BIG SISFS KA ELEVATE JDRF
Phase 1
Hardware Teardown & Analysis
Full teardown of Medtronic MiniMed Paradigm. Motor, gearhead, lead screw, reservoir, and drive chassis fully characterised from first principles.
✓ Complete
Phase 2
System Architecture & Full BOM
Complete Bill of Materials developed. MCU selection, TMC6300-LA motor driver, wireless stack, power subsystem, display, and firmware architecture all defined.
✓ Complete
Phase 3 — Current
Prototype Development
PCB design, embedded firmware development, and mechanical chassis fabrication underway. First functional prototype target: 6 months.
⬤ In Progress
Phase 4
Bench Testing & Validation
Dose accuracy, occlusion detection, RF noise, thermal, and EMI testing to IEC 60601-1 and IEC 62133.
Upcoming
Phase 5
CDSCO Submission & Approval
Clinical evaluation, CDSCO Class C regulatory application, and approval for Indian market launch.
Upcoming
Mytr.AI — The App

Your metabolic health,
intelligently managed.

Good morning,
Arjun 👋
Current Glucose
112
mg/dL
↗ In Range
Last 6 hours
Time in Range
87%
HbA1c Est.
6.4%
Active IOB
1.2U
🧠
AI suggests +0.3U correction
Based on your pattern & meal log
Calculate Bolus →
AI Insight
+0.3 U
Suggested correction
Time in range
87%
Today · ↑ 4%

Mytr.AI gives every person with diabetes the intelligence of a specialist in their pocket — tracking glucose, predicting trends, guiding dosing, and connecting to the Mytr AI Insulin Pump.

📊
Real-time Glucose Intelligence

CGM-synced tracking with AI trend prediction — know what your glucose will do before it happens.

💉
Smart Bolus Calculator

Personalised recommendations based on your carbs, current glucose, sensitivity factor, and active insulin on board.

🧠
Adaptive AI Learning

Learns your patterns — meals, activity, sleep — and continuously refines its guidance to match your body uniquely.

🔗
Mytr AI Pump Control

Wireless control of your insulin pump directly from the app — adjust basals, deliver boluses, review dose history.

Available today — no pump required. Start logging glucose, meals, and insulin, and let Mytr.AI begin learning your patterns from day one.

Start Using Mytr.AI Free →
Why We Exist

A system that failed millions.
We're fixing it.

🏥
The Access Gap
Over 77 million Indians live with diabetes, yet insulin pump therapy is inaccessible to nearly all of them. Imported pumps cost ₹3–5 lakhs — more than most families earn in a year.
🔬
Indigenous Engineering
The Mytr AI Insulin Pump is built from first principles in India — not licensed or adapted. Every component, algorithm, and design decision is made for the Indian patient and context.
🤝
Software + Hardware
The Mytr.AI app and Mytr AI Insulin Pump are one integrated system — intelligence and delivery working together for better outcomes, at every economic level.
Join the Movement

The future of diabetes care
in India starts here.

Patient, clinician, investor, or believer — we'd love to have you with us.

Try the Mytr.AI App → Contact the Team